Instil Bio, Inc.
TIL
$15.46
$0.1551.01%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 16.64% | 0.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 36.50% | -17.30% | |||
| Operating Income | -36.50% | 17.30% | |||
| Income Before Tax | 48.33% | -54.33% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 48.33% | -54.33% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 48.33% | -54.33% | |||
| EBIT | -36.50% | 17.30% | |||
| EBITDA | -41.21% | 18.05% | |||
| EPS Basic | 48.50% | -54.31% | |||
| Normalized Basic EPS | -44.57% | 26.04% | |||
| EPS Diluted | 48.50% | -54.31% | |||
| Normalized Diluted EPS | -44.57% | 26.04% | |||
| Average Basic Shares Outstanding | 0.32% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.32% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||